Enforcement of Judgments in Civil and Commercial Matters
China
12 September 2025
Commerce & Finance Law Offices has a strong track record representing biotech and pharmaceutical companies on their listings, especially Chapter 18A listings in the Hong Kong market. Meng Zhang is experienced in private equity financing and M&A by foreign investors. Key individuals in the healthcare capital markets practice include Wei Sun, Xiaoman Zhang, and Bo Wang.
Legal 500 Editorial commentary
Key clients
- CICC
- UBS Huatai
- Laekna,Inc.
- Beijing Century Hong Shui Hospital Management Ltd.
- Sangon Biotech (Shanghai) Co.,Ltd.
- LBC Sunshine Healthcare Fund II L.P.
- Neusoft Xikang Holdings Inc.
- Concord Healthcare Group Co., Ltd.
- MedSci Healthcare Holdings Limited
- 3D Medicines (Shanghai) Co., Ltd
- China Life Private Equity Investment
- Shanghai Duoning Biotechnology Co., Ltd.
Work highlights
Acted as PRC counsel to CICC as the sponsor and underwriter for Yaoshibang's Hong Kong listing.
Advised UBS and Huatai as sponsors and underwriters for the listing of HighTide in Hong Kong.
Acted as PRC legal advisor for Laekna Inc., assisting the sole sponsor in the IPO and listing on the Main Board of HKEx.
Other key lawyers
Yuanmeng Ma; Xiaqoman Zhang; Bo Wang; Meng Zhang; Wei Sun